Literature DB >> 12554642

Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells.

Ehud Cohen1, Albert Taraboulos.   

Abstract

Prion diseases are infectious, sporadic and inherited fatal neurodegenerations that are propagated by an abnormal refolding of the cellular prion protein PrP(C). Which chaperones assist the normal folding of PrP(C) is unknown. The linkage of familial Gerstmann- Sträussler-Scheinker (GSS) syndrome with proline substitutions in PrP raised the prospect that peptidylprolyl cis-trans isomerases (PPIases) may play a role in normal PrP metabolism. Here we used cyclo sporin A (CsA), an immunosuppressant, to inhibit the cyclophilin family of PPIases in cultured cells. CsA-treated cells accumulated proteasome-resistant, 'prion-like' PrP species, which deposited in long-lived aggresomes. PrP aggresomes also formed with disease-linked proline mutants when proteasomes were inhibited. These results suggest mechanisms whereby abnormally folded cytosolic PrP may in some cases participate in the development of spontaneous and inherited prion diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554642      PMCID: PMC140730          DOI: 10.1093/emboj/cdg045

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

Review 1.  The structural basis of protein folding and its links with human disease.

Authors:  C M Dobson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-02-28       Impact factor: 6.237

2.  Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome.

Authors:  A Navon; A L Goldberg
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

3.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.

Authors:  J Ma; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

5.  Separation and properties of cellular and scrapie prion proteins.

Authors:  R K Meyer; M P McKinley; K A Bowman; M B Braunfeld; R A Barry; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  A cellular gene encodes scrapie PrP 27-30 protein.

Authors:  B Oesch; D Westaway; M Wälchli; M P McKinley; S B Kent; R Aebersold; R A Barry; P Tempst; D B Teplow; L E Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

7.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

8.  Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

Authors:  K Atkinson; J Biggs; P Darveniza; J Boland; A Concannon; A Dodds
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

9.  Fluorescence microscopy: reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate.

Authors:  H Giloh; J W Sedat
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

10.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

View more
  24 in total

1.  Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.

Authors:  Monique Provansal; Stéphane Roche; Manuela Pastore; Danielle Casanova; Maxime Belondrade; Sandrine Alais; Pascal Leblanc; Otto Windl; Sylvain Lehmann
Journal:  Prion       Date:  2010-10-27       Impact factor: 3.931

2.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

3.  Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.

Authors:  Terry Kipkorir; Christopher M Colangelo; Laura Manuelidis
Journal:  Proteomics       Date:  2015-06-09       Impact factor: 3.984

4.  Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation.

Authors:  A G Kanthasamy; C Choi; H Jin; D S Harischandra; V Anantharam; A Kanthasamy
Journal:  Toxicol Lett       Date:  2012-09-17       Impact factor: 4.372

Review 5.  Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and disease.

Authors:  Triana Amen; Daniel Kaganovich
Journal:  Cell Mol Life Sci       Date:  2014-10-05       Impact factor: 9.261

6.  Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction.

Authors:  Tziona Ben-Gedalya; Lorna Moll; Michal Bejerano-Sagie; Samuel Frere; Wayne A Cabral; Dinorah Friedmann-Morvinski; Inna Slutsky; Tal Burstyn-Cohen; Joan C Marini; Ehud Cohen
Journal:  EMBO J       Date:  2015-10-05       Impact factor: 11.598

7.  Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells.

Authors:  Katarina M Luhr; Elin K Nordström; Peter Löw; Hans-Gustaf Ljunggren; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 8.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

9.  Changes in protein structure and distribution observed at pre-clinical stages of scrapie pathogenesis.

Authors:  Ariane Kretlow; Qi Wang; Michael Beekes; Dieter Naumann; Lisa M Miller
Journal:  Biochim Biophys Acta       Date:  2008-06-14

10.  Selective processing and metabolism of disease-causing mutant prion proteins.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.